Pharmacotherapy : a pathophysiologic approach /
Saved in:
| Edition: | 7th ed. |
|---|---|
| Imprint: | New York : McGraw-Hill Medical, c2008. |
| Description: | xxxii, 2559 p. : ill. (some col.) ; 29 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/7245265 |
Table of Contents:
- Pharmacoeconomics: principles, methods, and applications
- Health outcomes and quality of life
- Evidence-based medicine
- Documentation of pharmacy services
- Clinical pharmacokinetics and pharmacodynamics
- Pharmacogenetics
- Pediatrics
- Geriatrics
- Pharmacoepidemiology
- Clinical toxicology
- Emergency preparedness: indentification and management of biological exposures
- Emergency preparedness: identification and management of chemical and radiological exposures
- Cardiovascular testing
- Cardiopulmonary arrest
- Hypertension
- Heart failure
- Ischemic heart disease
- Acute coronary syndromes
- The arrhythmias
- Diastolic heart failure and the cardiomyopathies
- Venous thromboembolism
- Stroke
- Hyperlipidemia
- Peripheral arterial disease
- Use of vasopressors and inotropes in the pharmacotherapy of shock
- Hypovolemic shock
- Introduction to pulmonary function testing
- Asthma
- Chronic obstructive pulmonary disease
- Pulmonary hypertension
- Drug-induced pulmonary diseases
- Cystic fibrosis
- Evaluation of the gastrointestinal tract
- Gastroesophageal reflux disease
- Peptic ulcer disease
- Inflammatory bowel disease
- Nausea and vomiting
- Diarrhea, constipation, and irritable bowel syndrome
- Portal hypertension and cirrhosis
- Drug-induced liver disease
- Pancreatitis
- Viral hepatitis
- Drug therapy individualization in patients with hepatic disease or genetic alterations in drug metabolizing activity
- Quantification of renal function
- Acute renal failure
- Chronic kidney disease: progression-modifying therapies
- Chronic kidney disease: management of complications
- Hemodialysis and peritoneal dialysis
- Drug-induced kidney disease
- Glomerulonephritis
- Drug therapy individualization for patients with renal insufficiency
- Disorders of sodium and water homeostasis
- Disorders of calcium and phosphorus homestasis
- Disorders of potassium and magnesium homeostasis
- Acid-base disorders
- Evaluation of neurologic illness
- Multiple sclerosis
- Epilepsy
- Status epilepticus
- Acute management of the brain injury patient
- Parkinson's disease
- Pain management
- Headache disorders
- Evaluation of psychiatric illness
- Childhood disorders
- Eating disorders
- Alzheimer's disease
- Substance-related disorders: overview and depressants, stimulants, and hallucinogens
- Substance-related disorders: alcohol, nicotine, and caffeine
- Schizophrenia
- Depressive disorders
- Bipolar disorder
- Anxiety disorders I: generalized anxiety, panic, and social anxiety disorders
- Anxiety disorders II: posttraumatic stress disorder and obsessive-compulsive disorder
- Sleep disorders
- Developmental disabilities
- Diabetes mellitus
- Thyroid disorders
- Adrenal gland disorders
- Pituitary gland disorders
- Pregnancy and lactation: therapeutic considerations
- Contraception
- Menstruation-related disorders
- Endometriosis
- Hormone therapy in women
- Erectile dysfunction
- Management of benign
- Urinary incontinence
- Function and evaluation of the immune system
- Systemic lupus erythematosus and other collagen-vascular diseases
- Allergic and pseudoallergic drug reactions
- Solid-organ transplantation
- Osteoporosis and other metabolic bone diseases
- Rheumatoid arthritis
- Osteoarthritis
- Gout and hyperuricemia
- Glaucoma
- Allergic rhinitis
- Dermatologic drug reactions and self-treatable skin disorders
- Acne vulgaris
- Psoriasis
- Atopic dermatitis
- Hematopoiesis
- Anemias
- Coagulation disorders
- Sickle cell disease
- Drug-induced hematologic disorders
- Laboratory tests to direct antimicrobial pharmacotherapy
- Antimicrobial regimen selection
- Central nervous system infections
- Lower respiratory tract infections
- Upper respiratory tract infections
- Influenza
- Skin and soft-tissue infections
- Infective endocarditis
- Tuberculosis
- Gastrointestinal infections and enterotoxigenic poisonings
- Intraabdominal infections
- Parasitic diseases
- Urinary tract infections and prostatitis
- Sexually transmitted diseases
- Bone and joint infections
- Sepsis and septic shock
- Superficial fungal infections
- Invasive fungal infections
- Infections in immunocompromised patients
- Antimicrobial prophylaxis in surgery
- Vaccines, toxoids, and other immunobiologics
- Human immunodeficiency virus infection
- Cancer treatment and chemotherapy
- Breast cancer
- Lung cancer
- Colorectal cancer
- Prostate cancer
- Lymphomas
- Ovarian cancer
- Acute leukemias
- Chronic leukemias
- Multiple myeloma
- Myelodysplastic syndromes
- Skin cancer
- Hematopoietic stem cell transplantation
- Assessment of nutrition status and nutrition requirements
- Prevalence and significance of malnutrition
- Parenteral nutrition
- Enteral nutrition
- Nutritional considerations in major organ failure
- Obesity.
